
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 2206827-12-3 |
| Catalog No. | 2A-3180355 |
| Chinese Name | Sorafenib impurity 16/Ethyl (4-((2-(methylcarbamoyl)pyridin-4-yl)oxy)phenyl)carbamate |
| Molecular Formula | C16H17N3O4 |
| Molecular Weight | 315.32 |
| Density | 1.263±0.06 g/cm3(Predicted) |
| Boiling Point | 467.3±40.0 °C(Predicted) |
| PubChem ID | 383604985 |
| InChI | InChI=1S/C16H17N3O4/c1-3-22-16(21)19-11-4-6-12(7-5-11)23-13-8-9-18-14(10-13)15(20)17-2/h4-10H,3H2,1-2H3,(H,17,20)(H,19,21) |
| InChI Key | LVPAGQJMUWPNHG-UHFFFAOYSA-N |
| Transport Info | Product name: Ethyl (4-((2-(Methylcarbamoyl)pyridin-4-yl)oxy)phenyl)carbamate |
| Related Products in Analytical Standards | ||
|---|---|---|
| Ledipasvir impurity 2/N-[(1S)-1-[[(1R,3S,4S)-3-[6-[9,9-Difluoro-7-[2-[(6S)-5-formyl-5-azaspiro[2.4]hept-6-yl]-1H-imidazol-5-yl]-9H-fluoren-2-yl]-1H-benzimidazol-2-yl]-2-azabicyclo[2.2.1]hept-2-yl]carbonyl]-2-methylpropyl]-, methyl ester carbamic acid | 2040487-30-5 | 2A-3180331 |
| Ledipasvir impurity 8 | 2040487-27-0 | 2A-3180332 |
| Linagliptin Impurity H | 1646355-34-1 | 2A-3180346 |
| Pantoprazole Impurity 11 | 172282-50-7 | 2A-3180350 |
| Sorafenib impurity 14/Isopropyl (4-((2-(methylcarbamoyl)pyridin-4-yl)oxy)phenyl)carbamate | 2206827-14-5 | 2A-3180354 |
| Sorafenib impurity 24/N-Methyl-4-[4-[[2-[(methylamino)carbonyl]-4-pyridinyl]amino]phenoxy]-2-pyridinecarboxamide | 2004659-83-8 | 2A-3180359 |
| Tadalafil EP Impurity | 479545-76-1 | 2A-3180379 |
| Nintedanib impurity I | 334951-61-0 | 2A-3180392 |
| Nintedanib impurity I | 894783-61-0 | 2A-3180393 |
| Nintedanib impurity YZ | 1139455-52-9 | 2A-3180394 |
| Browse all Analytical Standards products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA